Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Timothy Green, M.D.
Family Practice · NOWATA, OK · NPI 1457739039
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 599 | 77 |
| Omeprazole | Omeprazole | 543 | 80 |
| Synthroid | Levothyroxine Sodium | 469 | 61 |
| Lisinopril | Lisinopril | 401 | 55 |
| Losartan Potassium | Losartan Potassium | 393 | 54 |
| Famotidine | Famotidine | 310 | 49 |
| Montelukast Sodium | Montelukast Sodium | 305 | 44 |
| Amlodipine Besylate | Amlodipine Besylate | 302 | 41 |
| Potassium Chloride | Potassium Chloride | 285 | 38 |
| Furosemide | Furosemide | 268 | 42 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 266 | 56 |
| Ozempic | Semaglutide | 266 | 36 |
| Tamsulosin Hcl | Tamsulosin Hcl | 260 | 31 |
| Eliquis | Apixaban | 256 | 31 |
| Gabapentin | Gabapentin | 241 | 40 |
| Fluticasone Propionate | Fluticasone Propionate | 231 | 54 |
| Hydrochlorothiazide | Hydrochlorothiazide | 195 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 191 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 188 | 31 |
| Metoprolol Succinate | Metoprolol Succinate | 173 | 24 |
| Metformin Hcl | Metformin Hcl | 171 | 24 |
| Fenofibrate | Fenofibrate | 169 | 18 |
| Carvedilol | Carvedilol | 168 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 153 | 25 |
| Trazodone Hcl | Trazodone Hcl | 150 | 26 |
| Simvastatin | Simvastatin | 148 | 23 |
| Metformin Hcl Er | Metformin Hcl | 138 | 19 |
| Pregabalin | Pregabalin | 137 | 20 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 130 | 18 |
| Sertraline Hcl | Sertraline Hcl | 126 | 17 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 115 | 20 |
| Glipizide Er | Glipizide | 112 | 14 |
| Ibuprofen | Ibuprofen | 105 | 19 |
| Invokana | Canagliflozin | 103 | 18 |
| Meloxicam | Meloxicam | 99 | 23 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 98 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 98 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 95 | 27 |
| Spiriva Respimat | Tiotropium Bromide | 95 | 18 |
| Allopurinol | Allopurinol | 91 | 11 |
| Buspirone Hcl | Buspirone Hcl | 88 | 15 |
| Atenolol | Atenolol | 87 | 11 |
| Prednisone | Prednisone | 86 | 31 |
| Mounjaro | Tirzepatide | 85 | 13 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 84 | 16 |
| Baclofen | Baclofen | 80 | 18 |
| Fosinopril Sodium | Fosinopril Sodium | 80 | 12 |
| Finasteride | Finasteride | 79 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 79 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 74 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 73 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 69 | 12 |
| Ondansetron Odt | Ondansetron | 69 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 65 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 61 | 18 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 58 | 13 |
| Spironolactone | Spironolactone | 58 | suppressed |
| Topiramate | Topiramate | 55 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 54 | suppressed |
| Torsemide | Torsemide | 53 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 52 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 49 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 47 | 12 |
| Pantoprazole Sodium | Pantoprazole Sodium | 45 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 45 | suppressed |
| Alogliptin | Alogliptin Benzoate | 44 | suppressed |
| Digoxin | Digoxin | 43 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 43 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 42 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 40 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 40 | suppressed |
| Xarelto | Rivaroxaban | 40 | suppressed |
| Memantine Hcl | Memantine Hcl | 36 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 35 | 27 |
| Easy Touch Pen Needle | Pen Needle, Diabetic | 35 | 16 |
| Entresto | Sacubitril/Valsartan | 34 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 34 | suppressed |
| Bupropion Xl | Bupropion Hcl | 33 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 33 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 32 | suppressed |
| Novolog Flexpen | Insulin Aspart | 32 | 12 |
| Pacerone | Amiodarone Hcl | 32 | suppressed |
| Lidocaine | Lidocaine | 28 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 27 | suppressed |
| Trulicity | Dulaglutide | 26 | suppressed |
| Fluconazole | Fluconazole | 25 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 25 | suppressed |
| Nifedipine Er | Nifedipine | 25 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 25 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 23 | suppressed |
| Jardiance | Empagliflozin | 23 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 22 | suppressed |
| Methotrexate | Methotrexate Sodium | 21 | suppressed |
| Mupirocin | Mupirocin | 21 | 13 |
| Sumatriptan Succinate | Sumatriptan Succinate | 21 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 21 | suppressed |
| Anastrozole | Anastrozole | 20 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 20 | suppressed |
| Methylprednisolone | Methylprednisolone | 20 | 16 |
| Oxycodone Hcl | Oxycodone Hcl | 20 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 20 | suppressed |
| Sucralfate | Sucralfate | 20 | suppressed |
| Phenobarbital | Phenobarbital | 19 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 18 | suppressed |
| Premarin | Estrogens, Conjugated | 18 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | suppressed |
| Alprazolam | Alprazolam | 17 | suppressed |
| Mirtazapine | Mirtazapine | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 17 | suppressed |
| Aripiprazole | Aripiprazole | 16 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 16 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 16 | suppressed |
| Sulfasalazine Dr | Sulfasalazine | 16 | suppressed |
| Telmisartan | Telmisartan | 16 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 16 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | suppressed |
| Nystatin | Nystatin | 14 | suppressed |
| Temazepam | Temazepam | 14 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 14 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 13 | suppressed |
| Methimazole | Methimazole | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | 12 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Invokamet Xr | Canagliflozin/Metformin Hcl | 12 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 12 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 11 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 11 | suppressed |
| Levetiracetam | Levetiracetam | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 11 | suppressed |
| Minoxidil | Minoxidil | 11 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error